Related Experiment Videos
Liver transplantation for viral hepatitis.
Geoffrey W McCaughan1, David J Koorey, Simone I Strasser
1AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown NSW 2050, Australia.
Hospital Medicine (London, England : 1998)
|February 3, 2005
Summary
Liver transplantation can treat liver failure from viral hepatitis. This review focuses on transplants for hepatitis B and C cirrhosis, but also touches on acute liver failure.
Area of Science:
- Hepatology
- Virology
- Transplantation Medicine
Background:
- Viral hepatitis, particularly B and C, can lead to severe liver damage and failure.
- Two main types of liver failure arise from viral hepatitis: acute (fulminant) and chronic.
- Liver transplantation is a critical treatment option for end-stage liver disease.
Purpose of the Study:
- To review liver transplantation for viral hepatitis-induced liver failure.
- To focus on the role of liver transplantation in managing hepatitis B and C-associated cirrhosis.
- To provide a concise overview of transplantation for fulminant hepatic failure.
Main Methods:
- Literature review of studies on liver transplantation for viral hepatitis.
- Analysis of outcomes for patients undergoing transplantation for hepatitis B and C cirrhosis.
- Synthesis of current clinical guidelines and evidence.
Main Results:
- Liver transplantation is effective for both acute fulminant hepatic failure and chronic liver failure due to viral hepatitis.
- Transplantation outcomes for hepatitis B and C cirrhosis are a significant focus of current research.
- Management strategies continue to evolve for preventing recurrence post-transplantation.
Conclusions:
- Liver transplantation is a viable and often necessary treatment for advanced viral hepatitis.
- Hepatitis B and C cirrhosis represent major indications for liver transplantation.
- Ongoing research aims to improve long-term outcomes and manage viral recurrence after liver transplant.